Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Systemic Inflammatory Response in Pediatric Cardiac Surgery
NCT05927233Phase 4Recruiting
- Sponsor
- Aga Khan University
- Start
- Apr 2023
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Aga Khan University. Started Apr 2023; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT05927233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05927233.